103162-77-2Relevant articles and documents
Synthesis and Antimicrobial Activity of Some New Coumarin and Dicoumarol Derivatives
El-Metwally, S. A.,Regal, M. K. A.,Shaban, S. S.
, p. 438 - 447 (2020)
Abstract: Phase transfer catalysis reaction of 4-hydroxy-6-methyl-2H-chromen-2-one with alkyl halides afforded C4 oxygen alkylation products of 2H-chromen-2-one derivatives in appreciative yield, whereas with phenyl isothiocyanate gives the C3 addition product of 4-hydroxy-6-methyl-2-oxo-N-phenyl-2H-chromene-3-carbothioamide, also one pot three component phase transfer reaction was investigated. Treatment of 4-hydroxy-6-methyl-2H-chromen-2-one with aromatic aldehydes in different molar ratios gives 3?arylidine and the dicoumarol derivatives. However pyrano chromene and pyrano pyridine were obtained by reaction of arylidine with ethyl acetoacetate through Michael cycloaddition reaction. The stability of pyrone ring in 3-arylidine and dicoumarol towards different nucleophilic reagents under reflux and/or fusion conditions has been studied by the action of, hydrazine hydrate, ammonium acetate, methyl amine and p-toluidine afforded compounds 1,2-bis(benzo[d][1,3]dioxol-5-ylmethylene)hydrazine, 1,2-bis(4-methoxybenzylidene)hydrazine and 2,6-bis((2,6-dihydroxy-3-methylphenyl)(hydroxy)methylene)-1-(4-methoxyphenyl)-4-(p-tolyl) piperidine-3,5-dione derivatives. The antimicrobial activity of some synthesized compounds has been investigated.
Anti-leishmanial activities of synthetic biscoumarins
Rahim, Fazal,Samreen,Ullah, Hayat,Fakhri, Muhammad Imran,Salar, Uzma,Perveen, Shahnaz,Khan, Khalid Mohammed,Choudhary, M. Iqbal
, p. 79 - 82 (2017/04/10)
Synthetic biscoumarins 1-19 were screened to check their anti-leishmanial activity. Out of nineteen, analogs 2 (IC50 = 46.95 ± 1.23 μM), 4 (IC50 = 63.03 ± 0.20 μM), 5 (IC50 = 41.35 ± 0.51 μM), 6 (IC50 = 35.62 ±
COUMARIN-BASED COMPOUNDS
-
Page/Page column 135, (2010/07/09)
Compounds including those of the Formula I where X, R1, R2 and subscript t are as defined herein, useful as γ-secretase inhibitors, are provided, as are compositions comprising the compounds, as well as methods for use of the compoun